Additionally, GIP receptor expression in hypothalamic regions and oligodendrocytes suggests central nervous system actions that may synergize with GLP-1 to reduce appetite and food intake while potentially mitigating GLP-1-associated nausea, thereby improving treatment tolerability [36,41,42]
:
Thus, they are not publicly available to protect the data used in this study
The very low rates of hypoglycemia are an additional advantage in vulnerable patients, such as the elderly or patients who live alone
When you add PT-141, the treatment also works on the central nervous system and helps with arousal
Mathew JP, Fontes ML, Tudor IC, Ramsay J, Duke P, Mazer CD, et al